首页 > 市场调查报告书 > 医疗设备

手术用器具

市场调查报告书

商品编码

1345386

全球子宫操纵器械市场 - 2023-2030

Global Uterine Manipulation Devices Market - 2023-2030

出版日期: 2023年09月06日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球子宫操纵器械市场在 2022 年达到 2.704 亿美元，预计到 2030 年将达到 4.251 亿美元，2023-2030 年预测期间复合年增长率为 5.9%。

预计推动全球子宫操纵设备市场增长的主要因素包括与女性生殖系统相关的疾病日益增多、技术进步不断增长以及对微创手术方法的需求不断增长。与女性生殖系统相关的典型疾病包括宫颈癌、子宫肌瘤、子宫内膜异位症、多囊卵巢综合征和间质性细胞增多症等。

根据世界卫生组织的数据，2022 年2 月，宫颈癌是全球女性中第四大典型癌症，评估了604,000 名新近患者，2020 年有超过342,000 人死亡。2020 年全球新发病例和死亡人数中约90% 是在2020 年出现的。低收入和中等收入国家。据评估，HPV 感染每年导致 530 000 例宫颈癌病例和超过 264 000 例宫颈癌死亡。

子宫操纵器的混合设计旨在提高腹腔镜女性生殖系统手术过程中的手术性能，包括麦卡特尼阴道管。常用的子宫操纵装置包括海绵棒、EEA sizer、ZUMI/HUMI 和 K-UMI 装置、Advincula Arch、RUMI II 系统、ClearView、Advincula Delineator 和 V-Care 以及市场上现有或正在开发的其他装置。

市场动态

妇科疾病病例不断增加

与女性生殖系统相关的典型疾病包括宫颈癌、子宫肌瘤、子宫内膜异位症、多囊卵巢综合征和间质性细胞增多症等。预计上述疾病病例的增加将在预测期内推动全球市场的增长。例如，根据国家癌症登记计划，乳腺癌和宫颈癌是女性中诊断出的非常典型的癌症。在印度女性中，宫颈癌占所有癌症的 6-29%。

此外，根据世界卫生组织的数据，子宫内膜异位症影响着全世界大约 10%（1.9 亿）的育龄妇女和女孩。此外，多囊卵巢综合症是一个重大的公共卫生问题，也是影响育龄女性的最常见的荷尔蒙失调症之一。据估计，这种疾病影响了 8-13% 的育龄女性，并且大约 70% 的患者未被诊断出来。

此外，根据2021年9月至2022年2月在中国南京南京医科大学附属医院进行的一项横断面研究，样本量为977名18-52岁的女性。最主要的妇科疾病是痛经，占45.96%，其次是多囊卵巢综合征，多囊卵巢综合症，占19.04%，子宫肌瘤，占14.23%，自然流产，占13.20%，不孕不育，占12.59%，卵巢功能障碍占11.16%，子宫内膜异位症占4.09%。

增加女性健康倡议

提高认识和支持女性生殖健康的倡议不断增加，也推动了预测期内全球市场的增长。例如，2022 年3 月，致力于提高认识、促进教育和支持子宫内膜异位症研究的非营利组织美国子宫内膜异位症基金会举办了几个週末的虚拟活动来纪念患者日，包括腹膜子宫内膜异位症和疼痛以及更严重的衰弱状况及其最终治疗。这种媒介的开发是为了帮助个人与他人联繫、了解他们的状况并分享他们的自我经历。

此外，FDA 妇女健康办公室与 NIH 妇女健康研究办公室合作，提高对参与临床试验的不同年龄、种族、民族背景和健康必需品的各种女性的认识。此外，消除宫颈癌的预防和筛查创新项目(PRESCRIP-TEC) 是一个为期三年的项目，从2021 年2 月到2024 年1 月，其研究重点是提高资源贫乏或难以获得宫颈癌诊断的地区的采用率。到达孟加拉国、印度、乌干达和斯洛伐克的环境。

不断增长的研究活动

提高子宫操纵器在不同子宫手术中的安全性的研究活动不断增加，正在推动全球市场的增长。例如，2022 年1 月，“获得性子宫肌层假性动脉瘤的超声成像：腹腔镜手术期间机械手作为异常原因的作用”的调查表明，尖端7 厘米的ClearView 子宫机械手在妇科手术中的结果得到了批准，表明它们在妇科手术中是安全的在外科手术期间使用。

此外，2023 年6 月，来自Jaume I 大学生物力学和人体工程学研究机构的Asociacion RUVID 研究人员、卡斯特罗综合大学医院腹部盆腔肿瘤手术转介科(UR-COAP) 和Fisabio 基金会设计了一种用于微创妇科手术的无创伤子宫操纵器。经过评估可以避免对初始肿瘤的伤害，降低操作子宫造成的伤害，并减少潜在致癌物的潜在迁移。

使用不当引起的并发症

儘管子宫操纵器提供了诸多好处，但使用子宫操纵器并非没有危险。操纵器的不当使用或放置可能会对子宫或周围组织造成损害，并可能导致出血或感染等复杂情况。如果腹腔镜子宫操纵器放置不准确或操纵时施加的压力过大，则有子宫穿孔的可能。这可能会导致出血或邻近器官损伤。

此外，如果腹腔镜子宫操纵器在使用前未正确消毒，则存在现场感染的危险。这可能导致术后感染，可能需要进一步治疗。使用腹腔镜子宫操纵器操纵子宫可能会引起出血，特别是在存在肌瘤或其他子宫异常的情况下。通过将适当的应用操纵器插入直接骨盆可视化下方的子宫中，可以避免这些复杂的情况。

缺乏外科专家

妇产科医生的供需差距不断扩大预计将减缓预测期内的市场增长。例如，根据《March of Dimes》的数据，超过 220 万美国育龄女性生活在“产妇护理沙漠”中，其中约 690 万身材矮小或无法获得妇科医疗保健。美国有一半的国家没有任何妇产科 (OB/GYN) 机构。

此外，美国卫生与公众服务部预计 2021 年妇产科医生数量将从 50,850 人减少至 47,490 人（7%），但到 2030 年需求预计将从 50,850 人增加至 52,660 人（4%）。此外，美国医学院协会(AAMC) 估计，到2032 年，医生短缺量约为122,000 名，妇产科也不例外。美国医学院协会 2023 年的初步数据显示，每个妇产科住院医师项目的申请数量从 2022 年的 663 人下降到 2023 年的 650 人。

Market Overview

Global Uterine Manipulation Devices Market reached US$ 270.4 million in 2022 and is expected to reach US$ 425.1 million by 2030, growing with a CAGR of 5.9% during the forecast period 2023-2030.

The primary factors expected to boost the global uterine manipulation devices market include the growing disorders associated with the female reproductive system, rising technological advancements, and growing demand for minimally invasive surgical approaches. Typical disorders associated with the female reproductive system includes cervical cancer, uterine fibroids, endometriosis, polycystic ovary syndrome, and interstitial cytosis, among others.

According to World Health Organization, in February 2022, cervical cancer was the fourth highly typical cancer diagnosed in females globally, with an assesed 604,000 recent patients and over 342,000 deaths in 2020. Approximately 90% of the recent cases and deaths worldwide in 2020 surfaced in low- and middle-income nations. The HPV infection is accountable for an assessed 530 000 cases of cervical cancer and over 264 000 cervical cancer deaths annually.

A mixture of uterine manipulators has been designed to enhance surgical performance during laparoscopic female reproductive system surgical procedures, including the McCartney vaginal tube. The commonly utilized uterine manipulation devices include sponge stick, EEA sizer, ZUMI/HUMI, and K-UMI devices, Advincula Arch, The RUMI II System, ClearView, Advincula Delineator, and V-Care, among others available on the market or under development.

Market Dynamics

Growing Cases of Gynecological Disorders

Typical disorders associated with the female reproductive system include cervical cancer, uterine fibroids, endometriosis, polycystic ovary syndrome, and interstitial cytosis, among others. The growing cases of the abovementioned disorders are expected to drive global market growth during the forecast period. For instance, according to the National Cancer Registry Programme, the cancer of breast and cervix uteri was the highly typical cancer diagnosed in females. Cervical cancer makes up for 6-29% of all cancers among females in India.

Also, according to the WHO, Endometriosis impacts approximately 10% (190 million) of reproductive-age women and girls worldwide. Moreover, PCOS is a significant public health problem and is among the most commonly diagnosed hormonal disorders impacting females of reproductive age. The disorder impacts an assessed 8-13% of females of reproductive age, and around 70% of patients are undiagnosed.

Moreover, according to a cross-sectional study conducted at a hospital affiliated with Nanjing medical university in Nanjing, China between September 2021 and February 2022, with a sample size of 977 women aged 18-52 years. The highly predominant gynecological condition was dysmenorrhea with 45.96% of cases, heeded by polycystic ovary syndrome, PCOS accounting for 19.04% of cases, uterine fibroids with 14.23% of cases, spontaneous abortion with 13.20% of cases, 12.59% cases of trouble conceiving, ovarian dysfunction accounting for 11.16% cases and endometriosis accounting for 4.09% of cases.

Increasing Female Health Initiatives

The increasing initiatives to promote awareness and support female reproduction health also drive the global market growth during the forecast period. For instance, in March 2022, the Endometriosis Foundation of America, Inc., a non-profit organization committed to increasing awareness, boosting education, and supporting endometriosis research hosted several weekends of virtual events to mark Patient Day, including peritoneal endometriosis and pain and more serious debilitating condition and its conclusive therapy. This medium is developed to assist individuals to join with others, understand their condition, and share their self-experiences.

Moreover, the FDA Office of Women's Health partnered with the NIH Office of Research on Women's Health to increase awareness regarding various females of distinct ages, races, ethnic backgrounds, and health necessities partaking in clinical trials. Further, the Prevention and Screening Innovation Project Toward Elimination of Cervical Cancer (PRESCRIP-TEC), a three-year project from February 2021 - January 2024 concentrates its investigation on improving the adoption of cervical cancer diagnoses in resource-poor or hard-to-reach environments of Bangladesh, India, Uganda and Slovakia.

Growing Research Activities

The increasing research activities to increase the saftey of uterine manipulators in distinct uterine sugeries are boosting the global market growth. For instance, in January 2022, the investigation "Ultrasound Imaging of Acquired Myometrial Pseudoaneurysm: The Role of Manipulators as an Unusual Cause during Laparoscopic Surgery" demonstrated approving outcomes for ClearView Uterine Manipulator, 7 cm tip in gynecological surgery, exhibiting that they are secure to be utilized during surgical operations.

Moreover, in June 2023, the Asociacion RUVID Researchers from the Biomechanics and Ergonomics research body of the Universitat Jaume I, the Abdomino-Pelvic Oncology Surgery Referral Unit (UR-COAP) of the General University Hospital of Castello and the Fisabio Foundation have designed an atraumatic uterine manipulator for minimally invasive gynecological procedures. Assessed to avert injury to the initial tumor, lower the harm done by manipulating the uterus and decrease the potential migration of potential carcinogens.

Complications Induced by Inapropriate Use

Despite the benefits offered by uterine manipulators, the use of uterine manipulators is not without hazards. Inappropriate usage or placement of the manipulator can provoke damage to the uterus or encompassing tissues and may direct intricacies like bleeding or infection. There is a chance of uterine perforation in the case if laparoscopic uterine manipulator is not placed accurately or too extensive pressure is applied during manipulation. This can guide to bleeding or damage to adjacent organs.

Also, there is a peril of infection at the site if the laparoscopic uterine manipulator is not sterilized properly prior to use. This can lead to postoperative infection, which may need further treatment. The manipulation of the uterus with the laparoscopic uterine manipulator can induce bleeding, particularly if there are fibroids or other uterine anomalies present. These sorts of intricacies can be averted by the appropriate application manipulator into the uterus underneath immediate pelvic visualization.

Lack of Surgical Specialists

The increasing gap in the demand and supply of Obstetricians and Gynecologists is expected to slow the market growth in the forecast period. For instance, according to the March of Dimes, over 2.2 million U.S. females of childbearing age living in "maternity care deserts," and around 6.9 million have undersized or no access to gynecological healthcare. Half of the nations in the United States do not have any obstetrics and gynecology (OB/GYN) establsihments.

Moreover, the U.S. Department of Health and Human Services in 2021, estimated that the number of OB-GYNs to drop from 50,850 to 47,490 (7%), however the need is estimated to grow from 50,850 to 52,660 (4%) by 2030. Further, the Association of American Medical Colleges (AAMC) estimated a shortage of around 122,000 medics by 2032, and OB/GYN is no anomaly. The initial 2023 data from the American Association of Medical Colleges discloses that the moderate number of applications per obstetrics and gynecology residence program dropped from 663 in 2022 to 650 in 2023.

Segment Analysis

The global uterine manipulation devices market is segmented based on product type, type, application, end-user and region.

Increasing Number of Hysterectomy Procedures Conducted

Hysterectomy is surgery to extract the uterus/womb, out of the procedures specific to females, hysterectomies are the second most performed surgery in the U.S. (after cesarean sections). NIH, estimations indicate that one out of nine females will experience a hysterectomy in their lifetime and that roughly 600,000 operations are conducted annually in the United States. Moreover, according to NIH, in India, the preponderance of hysterectomy procedures was 3.2%, the highest in Andhra Pradesh (8.9%) and the lower in Assam (0.9%). Rural India had elevated a preponderance than urban India.

Further, one out of three women in the U.S. have had a hysterectomy by age 60. Therefore, the growing female geriatric population will also contribute to the segment growth in the forecast period. For instance, according to the National Statistical Office (NSO)'s Elderly in India 2021 report, India's geriatric residents (aged 60 and above) were estimated to brush 194 million in 2031 from 138 million in 2021, a 41 percent growth over a decade.

Geographical Penetration

North America Accounted for Approximately 37.1% of the Market Share in 2022 Owing to the Growing Cases of Gynecological Disorders

The growing demand for gynecological surgeries owing to increasing cases of gynecological disorders in this region. For instance, according to the American Cancer Society's 2023, estimations around 13,960 fresh cases of invasive cervical cancer are expected to be diagnosed and, over 4,310 females are expected to die from cervical cancer by the end of 2023. Moreover, according to the US Department of Health and Human Services, Endometriosis is estimated to affect over 11% of American females between 15 and 44. It is extremely typical among females in their 30s and 40s and may cause it more difficult to acquire pregnancy.

Moreover, according to CDC, PCOS is among the highly typical reasons for female infertility, impacting 6% to 12%, accounting for around 5 million US females of reproductive age. Interstitial cystitis (IC) is highly typical, the disorder is estimated to impact 3 million to 8 million women and between 1 million to 4 million men in the United States. Further, the Centers for Disease and Prevention (CDC) reports that roughly 600,000 hysterectomies are conducted in the United States annually.

Similarly, according to Behavioral Risk Factor Surveillance System (BRFSS) or the National Health Interview Survey (NHIS), analysis of growing trends in hysterectomy prevalence by age and directional differences by race and ethnicity were observed with less than 2% of women aged 20-29 years and over 4 in 10 females aged 70-79 years documented undergoing hysterectomy. Furthermore, the increasing initiatives and availability of reimbursement policies in the United States ensures the North America's uterine manipulation devices market growth in the forecast period.

For instance, the Medicare covers a doctor considered medically necessary hysterectomy. Again, the U.S. Preventive Services Task Force (USPSTF) suggests screening for cervical cancer every 3 years with a Pap test in females aged 21 to 29 years, and for women ages 30 to 65 years, a Pap test screening every 3 years with high-risk human papillomavirus (hrHPV) testing every 5 years, or every 5 years with both types of tests. Again, the NCI Cervical Cancer 'Last Mile' Initiative, a public-private collaboration getting together federal agencies, industry associates, and professional associations to contribute proof regarding the precision and clinical significance of self-sampling-based HPV testing for cervical cancer screening.

Competitive Landscape

The major global players in the market include CooperSurgical Inc., MEDGYN PRODUCTS, INC., CONMED Corporation, Peters Surgical., Zhejiang Geyi Medical Instrument Co.,Ltd, Laborie, HTKD Medical, Bissinger Medizintechnik, Purple Surgical, Ningbo Xinwell Medical Technology Co., LTD., Utah Medical Products, Inc., and Panpac Medical Corp. among others.

COVID-19 Impact Analysis

According to an article titled, "Gynecological Surgery and COVID-19" published in July 2020, an estimated 28 million procedures were delayed or withdrawn globally because of the pandemic, forcing a hold on the diagnosis and treatment of over 2 million cancer patients. In Brazil, both the National Health Agency (ANS) and National Health Surveillance Agency (ANVISA) advised the postponement of elective and non-essential procedures, caused a significant impact on the number of surgical procedures that decreased by 33.4% in this period.

Moreover, according to a nationwide survey by the Japan Society of Obstetrics and Gynecology, the whole number of surgeries dropped from 129,648 in 2019 to 118,565 in 2020, accounting for 8.5%, for all surgical operations. Nevertheless, there was steep growth in the number of robotic procedures conducted in 2020 corresponded to that in 2019 for all inhabitants. The number of entire hysterectomies declined markedly from 15,385 in 2019 to 12,531 in 2020, a demonstrating a drop of 10.1%.

Again, earlier during the pandemic, ambulatory visitings at some medical centers in the U.S. dropped significantly, with a concurrent growth in telehealth visits. Yet, the transformation of in-person care to telemedicine care was inconsistent across experties. Procedure volumes were even dropped throughout the multiple specialties.

Surprisingly, actually volumes for some sorts of emergency department care were attenuated, including for some gynecologic disorders. COVID-19 has altered clinical and surgical approaches in benign gynecology. It has directed medics to begin employing telemedicine for gynecologic care more readily, and considerable gynecologists have continued to employ this approach of health care even when the pandemic has subsided.

By Product Type

Tintara Type
Hohl Type
Donnez Type
Advincula Arch Type
Others

By Type

Single-Use
Multi-Use

By Application

Hysterectomy

Partial Hysterectomy

Total Hysterectomy

Radical Hysterectomy

Laparoscopic Ovarian Cystectomy
Myomectomy
Others

By End-User

Hospitals
Gynecological Clinics
Ambulatory Surgical Canters
Academic & Research Centers
Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

In October 2021, Laborie Medical Technologies Corp. (Laborie), a specialist medical technology corporation, acquired Pe lvalon, Inc., a privately owned medical device corporation established in Redwood City, CA.
In September 2021, Boston Scientific Corporation, a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices, completed the acquisition of Devoro Medical, a privately held corporation. Devoro Medical specializes in designing minimally invasive devices for abnormal uterine bleeding.
In February 2021, CooperSurgical Inc., a market leader in the designing, manufacturing, and commercialization of medical devices utilized to advance women's healthcare and minimally invasive surgery completed the acquisition of AEGEA Medical. The acquisition was expected to allow the corporation to expand its women's healthcare product line.

Why Purchase the Report?

To visualize the global uterine manipulation devices market segmentation based on product type, type, application, end-users and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of uterine manipulation devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key product of all the major players.

The global uterine manipulation devices market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Type
3.3. Snippet by Application
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Cases of Gynecological Disorders
  - 4.1.1.2. Increasing Female Health Initiatives
  - 4.1.1.3. Growing Research Activities
- 4.1.2. Restraints
  - 4.1.2.1. Complications Induced
  - 4.1.2.2. Lack of Surgical Specialists
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. Distribution Channel Trend
5.7. SWOT Analysis
5.8. Russia-Ukraine War Impact Analysis
5.9. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Tintara Type*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Hohl Type
7.4. Donnez Type
7.5. Advincula Arch Type
7.6. Others

8. By Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.1.2. Market Attractiveness Index, By Type
8.2. Single-Use*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Multi-Use

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Hysterectomy*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.2.3. Partial Hysterectomy
- 9.2.4. Total Hysterectomy
- 9.2.5. Radical Hysterectomy
9.3. Laparoscopic Ovarian Cystectomy
9.4. Myomectomy
9.5. Others

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 10.2.3. Gynecological Clinics
- 10.2.4. Ambulatory Surgical Canters
- 10.2.5. Academic & Research Centers
- 10.2.6. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. CooperSurgical Inc.*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. MEDGYN PRODUCTS, INC.
13.3. CONMED Corporation
13.4. Peters Surgical.
13.5. Zhejiang Geyi Medical Instrument Co.,Ltd
13.6. Laborie
13.7. HTKD Medical
13.8. Bissinger Medizintechnik
13.9. Purple Surgical
13.10. Ningbo Xinwell Medical Technology Co., LTD.
13.11. Utah Medical Products, Inc.
13.12. Panpac Medical Corp.

LIST NOT EXHAUSTIVE

14. Appendix

14.1. About Us and Services
14.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球子宫操纵器械市场 - 2023-2030

Global Uterine Manipulation Devices Market - 2023-2030

市场概况

市场动态

目录

第 1 章：方法和范围

第 2 章：定义和概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：行业分析

第 6 章：COVID-19 分析

第 7 章：按产品类型

第 8 章：按类型

第 9 章：按应用

第 10 章：最终用户

第 11 章：按地区

第 12 章：竞争格局

第 13 章：公司简介

第 14 章：附录